Detalhe da pesquisa
1.
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
Biol Blood Marrow Transplant
; 21(6): 1074-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805300